Dr. Mower helped invent an automatic implantable defibrillator, which corrects a patient’s inefficient heartbeat with an electric shock to resume its regular rhythm.
The FDA approved the technology in 1985, and it was eventually sold to pharmaceutical company Eli Lilly. Dr. Mower then became the company’s director of medical research.
Dr. Mower attended Johns Hopkins and the University of Maryland School of Medicine. He served as chief of cardiology at Sinai Hospital for several years.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
